While cancer overall is characterized by broad oncomiR up-regulation and loss of tumor-suppressive miRNAs, POLE-mutant tumors display a distinct profile marked by global down-regulation, reflecting alternative evolutionary strategies of tumor progression. The gene discussed is POLE; the disease is cancer.